Company / Total Assets
Crinetics Pharmaceuticals, Inc. Total Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.1B
FY2025
5-year range
$351.0M / $1.4B
FY2021-FY2025
Trend
-21.5%
vs FY2024
Sector context
#74 of 214
Health Care
What the data says
At $1.1B, Crinetics Pharmaceuticals, Inc.'s total assets ranks #74 of 214 in the Health Care sector. Total Assets has fluctuated over the past 9 years, ranging from $16M in FY2017 to $1.4B in FY2024.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of +43.8%.
Improved from $635M to $1.1B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +47.3%
- 5-Year CAGR
- +43.8%
- 10-Year CAGR
- -
Sector benchmark
#74 of 214 in Health CareTop 35% of 214This company $1.1B Sector average $7.5B
▼
-84.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +43.8%, indicating consistent growth.
- In FY2025, total assets decreased 21.5% year-over-year.
- Ranks #74 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | -21.5% |
| FY2024 | $1.4B | +125.8% |
| FY2023 | $635.4M | +80.4% |
| FY2022 | $352.2M | +0.3% |
| FY2021 | $351.0M | +91.3% |
| FY2020 | $183.4M | +40.7% |
| FY2019 | $130.4M | -23.9% |
| FY2018 | $171.4M | +999.0% |
| FY2017 | $15.6M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026